DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

173 hedge funds and large institutions have $1.25B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
-29
Holders Change %
-14.36%
% of All Funds
3.04%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
28
Increased
64
Reduced
58
Closed
56
Calls
$15.1M
Puts
$4.49M
Net Calls
+$10.6M
Net Calls Change
+$8.12M

Top Buyers

1
State Street
State Street
Massachusetts
$78.3M
2
CC
Commodore Capital
New York
$26.1M
3
EC
EcoR1 Capital
California
$25.2M
4
GPP
Great Point Partners
Connecticut
$16.1M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$27.2M

Top Sellers

1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
$0
2
Wellington Management Group
Wellington Management Group
Massachusetts
$10.8M
3
PA
Perceptive Advisors
New York
$0
4
EA
Emerald Advisers
Pennsylvania
$0
5
NAMA
Nikko Asset Management Americas
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SFP
226
Sterling Financial Planning
New Jersey
– -$4K -100 Closed
Toronto Dominion Bank
227
Toronto Dominion Bank
Ontario, Canada
– -$1K -30 Closed
6 7 8 9
10